Author(s): Youxiang Su , Jian Xin , Shang Gao, Yun Song , Renchang Chen , Nianhu Li and Ning Shen
Although more and more evidence has supported that the interaction between sarcopenia and Corona Virus Disease 2019(COVID-19) could be bidirectional and may form a vicious circle, the common mechanism of its occurrence is still not fully elucidated. Our study reveals the common pathogenesis and potential therapeutic targets of sarcopenia and COVID-19. These common pathways and potential drugs may provide new ideas for further mechanism research.
